Literature DB >> 12707849

Prion diseases.

Edward McKintosh1, Sarah J Tabrizi, John Collinge.   

Abstract

Prion diseases are incurable neurodegenerative conditions affecting both animals and humans. They may be sporadic, infectious, or inherited in origin. Human prion diseases include Creutzfeldt-Jakob desease (CJD), Gerstmann-Straussler-Scheinker disease, kuru, and fatal familial insomnia. The appearance of variant CJD, and the demonstration that is caused by strains indistinguishable from bovine spongiform encephalopathy (BSE) in cattle, has led to the threat of a major epidemic of human prion disease in the UK and other countries where widespread dietary exposure to bovine prions has occurred. This article reviews the history and epidemiology of these diseases, and then focuses on important areas of current research in human prion disorders.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12707849     DOI: 10.1080/13550280390194082

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  69 in total

1.  Fatal familial insomnia: a second kindred with mutation of prion protein gene at codon 178.

Authors:  R Medori; P Montagna; H J Tritschler; A LeBlanc; P Cortelli; P Tinuper; E Lugaresi; P Gambetti
Journal:  Neurology       Date:  1992-03       Impact factor: 9.910

Review 2.  A 'unified theory' of prion propagation.

Authors:  C Weissmann
Journal:  Nature       Date:  1991-08-22       Impact factor: 49.962

3.  Prion protein selectively binds copper(II) ions.

Authors:  J Stöckel; J Safar; A C Wallace; F E Cohen; S B Prusiner
Journal:  Biochemistry       Date:  1998-05-19       Impact factor: 3.162

4.  Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease.

Authors:  M S Palmer; A J Dryden; J T Hughes; J Collinge
Journal:  Nature       Date:  1991-07-25       Impact factor: 49.962

5.  The scrapie enigma: insights from radiation experiments.

Authors:  T Alper
Journal:  Radiat Res       Date:  1993-09       Impact factor: 2.841

6.  Mice devoid of PrP are resistant to scrapie.

Authors:  H Büeler; A Aguzzi; A Sailer; R A Greiner; P Autenried; M Aguet; C Weissmann
Journal:  Cell       Date:  1993-07-02       Impact factor: 41.582

7.  Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein.

Authors:  H Büeler; M Fischer; Y Lang; H Bluethmann; H P Lipp; S J DeArmond; S B Prusiner; M Aguet; C Weissmann
Journal:  Nature       Date:  1992-04-16       Impact factor: 49.962

8.  Fatal familial insomnia, a prion disease with a mutation at codon 178 of the prion protein gene.

Authors:  R Medori; H J Tritschler; A LeBlanc; F Villare; V Manetto; H Y Chen; R Xue; S Leal; P Montagna; P Cortelli
Journal:  N Engl J Med       Date:  1992-02-13       Impact factor: 91.245

9.  Prolongation of scrapie incubation period by an injection of dextran sulphate 500 within the month before or after infection.

Authors:  C F Farquhar; A G Dickinson
Journal:  J Gen Virol       Date:  1986-03       Impact factor: 3.891

10.  A glycolipid-anchored prion protein is endocytosed via clathrin-coated pits.

Authors:  S L Shyng; J E Heuser; D A Harris
Journal:  J Cell Biol       Date:  1994-06       Impact factor: 10.539

View more
  14 in total

1.  Destabilizing interactions among [PSI(+)] and [PIN(+)] yeast prion variants.

Authors:  Michael E Bradley; Susan W Liebman
Journal:  Genetics       Date:  2003-12       Impact factor: 4.562

2.  Reconstructing the fungal tree of life using phylogenomics and a preliminary investigation of the distribution of yeast prion-like proteins in the fungal kingdom.

Authors:  Edgar M Medina; Gary W Jones; David A Fitzpatrick
Journal:  J Mol Evol       Date:  2011-09-22       Impact factor: 2.395

3.  Crystallization and preliminary X-ray diffraction analysis of a specific VHH domain against mouse prion protein.

Authors:  Romany N N Abskharon; Sameh H Soror; Els Pardon; Hassan El Hassan; Giuseppe Legname; Jan Steyaert; Alexandre Wohlkonig
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-11-26

4.  Informed consent should be obtained from patients to use products (skin substitutes) and dressings containing biological material.

Authors:  S Enoch; H Shaaban; K W Dunn
Journal:  J Med Ethics       Date:  2005-01       Impact factor: 2.903

Review 5.  GroEL-mediated protein folding: making the impossible, possible.

Authors:  Zong Lin; Hays S Rye
Journal:  Crit Rev Biochem Mol Biol       Date:  2006 Jul-Aug       Impact factor: 8.250

6.  Strain fidelity of chronic wasting disease upon murine adaptation.

Authors:  Christina J Sigurdson; Giuseppe Manco; Petra Schwarz; Pawel Liberski; Edward A Hoover; Simone Hornemann; Magdalini Polymenidou; Michael W Miller; Markus Glatzel; Adriano Aguzzi
Journal:  J Virol       Date:  2006-10-04       Impact factor: 5.103

7.  Polymorphisms at codons 56 and 174 of the prion-like protein gene (PRND) are not associated with sporadic Creutzfeldt-Jakob disease.

Authors:  Byung-Hoon Jeong; Nam-Ho Kim; Jae-Il Kim; Richard I Carp; Yong-Sun Kim
Journal:  J Hum Genet       Date:  2005-06-03       Impact factor: 3.172

8.  Induction of cerebral beta-amyloidosis: intracerebral versus systemic Abeta inoculation.

Authors:  Yvonne S Eisele; Tristan Bolmont; Mathias Heikenwalder; Franziska Langer; Laura H Jacobson; Zheng-Xin Yan; Klaus Roth; Adriano Aguzzi; Matthias Staufenbiel; Lary C Walker; Mathias Jucker
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-21       Impact factor: 11.205

9.  Creutzfeldt-Jakob disease in Slovenia from 1985 to 2003.

Authors:  Mara Popović; Damjan Glavac; Sava Smerkolj; Viktor Svigelj; Gregor Kalan; Vesna Galvani; Maja Cernilec; Maja Bresjanac
Journal:  Wien Klin Wochenschr       Date:  2004-08-31       Impact factor: 1.704

10.  Opposing roles of prion protein in oxidative stress- and ER stress-induced apoptotic signaling.

Authors:  Vellareddy Anantharam; Arthi Kanthasamy; Christopher J Choi; Dustin P Martin; Calivarathan Latchoumycandane; Jüergen A Richt; Anumantha G Kanthasamy
Journal:  Free Radic Biol Med       Date:  2008-09-13       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.